A sustainable, efficient, and scalable protocol for the Henry reaction between various aldehydes and nitroalkanes is presented, utilizing 1-(3-(dimethylamino)propyl)-3-ethylcarbodiimide hydrochloride (EDC·HCl) as an organoacid. The reaction proceeds under solvent-free, room temperature conditions at acidic pH, delivering β-nitro alcohols in excellent yields of up to 99%. The methodology demonstrates a broad substrate scope, accommodating both electron-rich and electron-deficient aldehydes. Notably, the protocol operates under base-free conditions, suppresses elimination of byproducts, and is readily scalable to the gram level without loss in efficiency. These features make the process a valuable contribution to the green and practical pharmaceutical industry.
No takes yet. Share an insight, caveat, or question.
Shukla et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: